Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Development deals
Biotech
Lilly crafts deal with UK biotech for new ALS antibodies
Alchemab and Lilly will work together on up to five new antibodies meant to treat the devastating neurological disease.
Darren Incorvaia
Jan 9, 2025 10:55am
Roche's Chugai inks Swiss ADC deal potentially worth over $780M
Jan 8, 2025 8:00am
Candid unwraps 3 collabs to develop new T-cell engagers
Dec 16, 2024 11:59am
Genmab buys 2nd antibody from Scancell in deal worth up to $630M
Dec 4, 2024 11:55am
GSK offers Rgenta up to $500M biobucks per target in RNA deal
Dec 4, 2024 8:00am
Gilead advances ADC dreams with potential $465M deal
Dec 3, 2024 10:54am
